6 Results for "

Mklp2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Mklp2" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-101298
CAS No.: 57046-73-8
Purity:  99.87%
Target:  

Kinesin

Research Areas:  

Neurological Disease

Paprotrain is a cell-permeable inhibitor of the kinesin MKLP-2, inhibits the ATPase activity of MKLP-2 with an IC50 of 1.35 μM and a Ki of 3.36 μM and shows a moderate inhibition activity on DYRK1A with an IC50 of 5.5 μM.
loading...
    loading...
Cat. No.: HY-RS07272
Research Areas:  

Others

KIF20A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF20A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-170850
CAS No.: 2929345-46-8
Target:  

Kinesin

Research Areas:  

Cancer

MKLP2-IN-1 (compound 12a) is an inhibitor of MKLP2 with good oral bioavailability. MKLP2-IN-1 inhibits the microtubule-stimulated ATPase activity of recombinant MKLP2 in vitro and suppresses tumor growth in a mouse Calu-6 lung cancer model .
loading...
    loading...
Cat. No.: HY-161112
CAS No.: 2840558-89-4
Target:  

Kinesin

Research Areas:  

Others

LG157 is a potent inhibitor of mitotic kinesin-like protein 2 (MKLP2) .
loading...
    loading...
Cat. No.: HY-101298R
CAS No.: 57046-73-8
Research Areas:  

Neurological Disease

Paprotrain (Standard) is the analytical standard of Paprotrain (HY-101298). This product is intended for research and analytical applications. Paprotrain is a cell-permeable inhibitor of the kinesin MKLP-2, inhibits the ATPase activity of MKLP-2 with an IC50 of 1.35 μM and a Ki of 3.36 μM and shows a moderate inhibition activity on DYRK1A with an IC50 of 5.5 μM.
loading...
    loading...
Cat. No.: HY-104023
CAS No.: 891849-87-9
Research Areas:  

Cancer

ZK-Thiazolidinone is an ATP-competitive Polo-like kinase 1 (Plk1) inhibitor with an IC50 of 19 nM. ZK-Thiazolidinone inhibits tumor cell proliferation, induces cell cycle arrest and typical mitotic defects. ZK-Thiazolidinone impairs the recruitment of γ-tubulin and Aurora A kinase to centrosomes, resulting in failure of bipolar spindle maintenance and sister chromatid arm cohesion.\nZK-Thiazolidinone is applicable for cancer research .
loading...
    loading...